Wells Fargo raised the firm’s price target on Edgewell Personal Care (EPC) to $22 from $20 and keeps an Overweight rating on the shares. Edgewell is cheap and the portfolio is much improved following the divestiture of the Feminine Care business, the firm says. This is why Wells stays Overweight and raises its target at a higher price to earnings, balanced by still needed visibility into an expected ramp in the second half of 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target raised to $21 from $19 at Barclays
- Edgewell Personal Care Affirms No Material Changes to 2025 Risk Profile Disclosures
- Edgewell Personal Care Bets on Back-Half Turnaround
- Edgewell Reaffirms Outlook After Feminine Care Divestiture
- Edgewell Personal Care sees FY26 adjusted EPS $1.70-$2.10, consensus $2.34
